Jones Soda grants 242,425 RSUs to director

SIRKIN CLIVE M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

SIRKIN CLIVE M reported acquisition or exercise transactions in this Form 4 filing.

Jones Soda Co. granted director Clive M. Sirkin 242,425 restricted stock units (RSUs) on July 15, 2026. Each RSU represents one share of common stock upon settlement. 50% of the award is scheduled to vest on July 31, 2026, 25% on September 30, 2026, and 25% on December 31, 2026.

Insider Trade Summary

Grant/Award: 242,425 shares

Grant/Award 1 txn

Insider SIRKIN CLIVE M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2	242,425	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 242,425 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's common stock upon settlement.
2. F2. On July 15, 2026, the reporting person was granted 242,425 RSUs, of which 50% are scheduled to vest into shares on July 31, 2026, an additional 25% are scheduled to vest into shares on September 30, 2026, and the remaining 25% are scheduled to vest into shares on December 31, 2026. Upon vesting, the reporting person will receive a number of shares of the issuer's common stock equal to the number of RSUs that vest on that date.

Key Figures

RSUs granted: 242,425 RSUs Underlying common shares: 242,425 shares Vesting on July 31, 2026: 50% +3 more

6 metrics

RSUs granted 242,425 RSUs Grant to director Clive M. Sirkin on July 15, 2026

Underlying common shares 242,425 shares Each RSU represents one share of common stock upon settlement

Vesting on July 31, 2026 50% First tranche of RSU award scheduled to vest into shares

Vesting on September 30, 2026 25% Second tranche of RSU award scheduled to vest into shares

Vesting on December 31, 2026 25% Final tranche of RSU award scheduled to vest into shares

RSUs held after transaction 242,425 RSUs Total derivative equity position reported following the grant

Key Terms

Restricted Stock Units, contingent right, vest

3 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one (1) share of the issuer's common stock"

vest financial

"50% are scheduled to vest into shares on July 31, 2026, an additional 25% are scheduled"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award did Clive M. Sirkin receive from JSDA?

Clive M. Sirkin received a grant of 242,425 restricted stock units (RSUs) from Jones Soda Co. on July 15, 2026. Each RSU represents one share of common stock, giving him rights to receive shares as the RSUs vest over time.

How many JSDA shares are underlying Clive M. Sirkin’s new RSU grant?

The award covers 242,425 RSUs, each representing the right to receive one share of Jones Soda common stock. If all RSUs vest and settle, Sirkin would receive 242,425 shares, subject to the scheduled vesting dates disclosed in the grant terms.

What is the vesting schedule for Clive M. Sirkin’s JSDA RSUs?

Sirkin’s 242,425 RSUs vest in three tranches: 50% on July 31, 2026, 25% on September 30, 2026, and the remaining 25% on December 31, 2026. Shares of common stock are delivered as the RSUs vest on each date.

Did Clive M. Sirkin buy or sell JSDA shares in this insider transaction?

The reported transaction is an equity award, not a market trade. Sirkin acquired 242,425 RSUs as a grant, with no open-market purchase or sale of Jones Soda common stock disclosed in this insider report.

What are Clive M. Sirkin’s JSDA holdings after the RSU grant?

After the award, Sirkin holds 242,425 RSUs directly, according to the reported position. These RSUs correspond to potential future shares of Jones Soda common stock, deliverable as the units vest on the specified 2026 dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 07:50 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SIRKIN CLIVE M

(Last) (First) (Middle)

1522 WESTERN AVE., SUITE 24150

(Street)

SEATTLE WASHINGTON 98101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JONES SODA CO. [ JSDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/15/2026		A		242,425		(2)	(2)	Common Stock	242,425	$0	242,425	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's common stock upon settlement.

2. On July 15, 2026, the reporting person was granted 242,425 RSUs, of which 50% are scheduled to vest into shares on July 31, 2026, an additional 25% are scheduled to vest into shares on September 30, 2026, and the remaining 25% are scheduled to vest into shares on December 31, 2026. Upon vesting, the reporting person will receive a number of shares of the issuer's common stock equal to the number of RSUs that vest on that date.

	/s/ Brian Meadows, Attorney-in-Fact for Clive Sirkin	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)